Carbamic Acid

Carbamic Acid

SCHEMBL18813114

Cn1ncc2cc(-n3nnc4cnc(NC5CCCC5)nc43)ccc21.NC(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 10/20 0.55
▸ GSK3A P49840 3/20 0.52
▸ GSK3B P49841 3/20 0.52
▸ SYK P43405 2/20 0.44
▸ FAAH O00519 1/20 0.41
▸ PDE4B Q07343 1/20 0.39
▸ AURKA O14965 2/20 0.39
▸ CCNA2 P20248 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CCNA1 P78396 2/20 0.38
▸ MAPK8 P45983 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ MAPK10 P53779 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16022201 0.88 MAPK6 (0.62) MAPK6GSK3AGSK3BSYKPDE4B
Carbamic Acid SCHEMBL18813077 0.86 MAPK6 (0.55) MAPK6GSK3AGSK3BAURKACCNA2
Carbamic Acid SCHEMBL18813123 0.84 MAPK6 (0.55) MAPK6GSK3AGSK3BAURKACCNA2
Carbamic Acid SCHEMBL18813125 0.84 MAPK6 (0.55) MAPK6GSK3AGSK3BAURKACCNA2
Carbamic Acid SCHEMBL18813174 0.83 MAPK6 (0.56) MAPK6GSK3AGSK3BAURKACCNA2
Carbamic Acid SCHEMBL18813041 0.83 MAPK6 (0.56) MAPK6GSK3AGSK3BSYKAURKA
Carbamic Acid SCHEMBL18813026 0.83 GSK3A (0.56) MAPK6GSK3AGSK3BSYK
Carbamic Acid SCHEMBL18813046 0.82 MAPK6 (0.55) MAPK6GSK3AGSK3BAURKAMAPK8
Carbamic Acid SCHEMBL18813052 0.82 MAPK6 (0.63) MAPK6GSK3AGSK3BAURKACCNA2
Carbamic Acid SCHEMBL18813033 0.82 MAPK6 (0.54) MAPK6GSK3AGSK3BAURKACCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP claimed
Send feedback